Topic: COVID-19 treatment
Molnupiravir: New drug to treat COVID-19
On October 1, 2021, Pharmaceutical company “Merck and Ridgeback Biotherapeutics” announced the early results of Phase-3 trials of its anti-viral drug called molnupiravir. As per the results, Molnupiravir...
WHO warns against use of ivermectin to treat Covid-19
The Health Minister of Goa recently recommended the use of “Ivermectin” to all people above the age of eighteen years. However, the World Health Organisation has warned against...
EpicVacCorona: Second COVID-19 Vaccine approved by Russia
The Russian Authorities have approved a new COVID-19 vaccine called “EpicVacCorona”. It is a two shot vaccine. Key Highlights EpiVacCorona is a peptide-based vaccine. Sputnik V was the... COVAXIN to use Alhydroxiquim-II to boost Immune Response
The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has...
US FDA authorizes to use blood plasma for Covid-19 treatment
The Food and Drug Administration (FDA) of America has authorized the use of blood plasma from the COVID-19 survivors. It will be used to treat the disease. As...
DCGI allows use of “Itolizumab” for moderate to severe COVID-19 cases
On July 11, 2020, the Dugs Controller General of India (DCGI) granted restricted emergency use of Itolizumab for moderate to severe COVI-19 patients. Highlights Itolizumab is a monoclonal... India approves second Vaccine Trial
The Drug Controller General of India approved to begin vaccine trial of Zydus Cadila. The firm is to conduct the vaccine trials in two phases. This is the...
